← Back to Patent Explorer
US5437292A Expired / Lapsed US ⏱️ 0.0 years remaining

Method for sealing blood vessel puncture sites

Assignee: Bioseal LLC
•
Filing: 1993-11-19
•
Granted: 1995-08-01
•
Expires: 2013-11-19
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract A method for percutaneous sealing of punctures in arterial and venous blood vessels is provided. After catheterization of any vessel or organ for diagnostic or interventional procedures or endoscopic or orthopedic procedures involving the intentional puncture and penetration of a vessel wall, or the accidental puncture of a vessel wall, separate solutions containing fibrinogen and thrombin, respectively, are introduced into the tissue surrounding the puncture site. The solutions are allowed to mix forming a semisolid gel at the time of application at the puncture site. The gel further hardens around the site to seal the puncture closed preventing the leakage of blood. Solutions of antibiotics and epinephrine as well as agents that slow clot breakdown may be included in the mixture. An apparatus for accomplishing the method is also disclosed.

Inventors

  • 👤 Nicholas Kipshidze
  • 👤 Victor Nikolychik
  • 👤 John E. Baker

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 01:12
CPC Classifications
A; A61; A61B; A61B17/00; A61B17/0057; A61B17/00491; A61B2017/00495

Claims Analysis

Total Claims: 20
Claim 1
Independent Claim 270 words
A method for sealing a puncture site in the wall of a blood vessel, the puncture site having been created accidentally, or intentionally during an endovascular or surgical procedure, wherein a substantially tubular percutaneous delivery device is positioned adjacent a blood vessel puncture site without penetrating the vessel, the method comprising the steps of: preparing a supply of a first solution containing fibrinogen; placing said fibrinogen-containing solution in a first syringe apparatus; preparing a supply of a second solution containing thrombin; placing said thrombin-containing solution in a second syringe apparatus; applying occlusive compression to the blood vessel at a position upstream of the puncture site; releasing the occlusive compression for a brief period of time to enable the puncture site to release an amount of blood into the tissue surrounding the puncture site, sufficient to surround the immediate vicinity of the puncture site, and thereafter reapplying the occlusive compression to stop release of blood from the puncture site; connecting the first and second syringe apparatus in simultaneous fluid communication with a mixing region and thereafter the delivery device so as to enable mixing of the fibrinogen and thrombin solutions prior to delivery to the puncture site; actuating the first and second syringe apparatus so as to substantially simultaneously introduce the fibrinogen- and thrombin-containing solutions into the mixing region to form a gel and thereafter into the delivery device, and into the tissue of the patient adjacent to the puncture site but not into the blood vessel, so as to enable the gel to thereafter substantially solidify around the puncture site and seal the puncture site against further release of blood.
Claim 2
Independent Claim 270 words
A method for sealing a puncture site in the wall of a blood vessel, the puncture site having been created accidentally, or intentionally during an endovascular or surgical procedure, wherein a substantially tubular percutaneous delivery device is positioned adjacent a blood vessel puncture site without penetrating the vessel, the method comprising the steps of: preparing a supply of a first solution containing fibrinogen; placing said fibrinogen-containing solution in a first syringe apparatus; preparing a supply of a second solution containing thrombin; placing said thrombin-containing solution in a second syringe apparatus; applying occlusive compression to the blood vessel at a position upstream of the puncture site; releasing the occlusive compression for a brief period of time to enable the puncture site to release an amount of blood into the tissue surrounding the puncture site, sufficient to surround the immediate vicinity of the puncture site, and thereafter reapplying the occlusive compression to stop release of blood from the puncture site; connecting the first and second syringe apparatus in simultaneous fluid communication with a mixing region and thereafter the delivery device so as to enable mixing of the fibrinogen and thrombin solutions prior to delivery to the puncture site; actuating the first and second syringe apparatus so as to substantially simultaneously introduce the fibrinogen- and thrombin-containing solutions into the mixing region to form a gel and thereafter into the delivery device, and into the tissue of the patient adjacent to the puncture site but not into the blood vessel, so as to enable the gel to thereafter substantially solidify around the puncture site and seal the puncture site against further release of blood.
Claim 3
Dependent Claim 125 words
The method for sealing the wall of a blood vessel having a puncture site therein according to claim 1, further including the steps of: disconnecting said first and second syringe apparatus from the delivery device after introducing the solutions which will form a gel into the tissue adjacent the puncture site; introducing a deflated, liquid-filled balloon apparatus into and through the delivery device; positioning the balloon apparatus into the tissue above the puncture site; inflating the balloon apparatus prior to solidification of the gel formed from the mixed solutions such that the balloon apparatus presses against the gel, and in turn the blood vessel, to prompt closure of the puncture site; and deflating and removing the balloon apparatus prior to final solidification of the gel.
Claim 4
Dependent Claim 40 words
The method for sealing the wall of a blood vessel having a puncture site therein according to claim 1, wherein a sufficient amount of fibrinogen is used, to obtain a concentration of fibrinogen in the matrix, of approximately 2.0-15.0 mg/ml.
Claim 5
Dependent Claim 41 words
The method for sealing the wall of a blood vessel having a puncture site therein according to claim 1, wherein a sufficient amount of thrombin is used, to obtain a concentration of thrombin in the matrix, of approximately 10-500 International Units/ml.
Claim 6
Dependent Claim 33 words
The method for sealing the wall of a blood vessel having a puncture site therein according to claim 1, wherein calcium is added to one or more of the thrombin and fibrinogen solutions.
Claim 7
Dependent Claim 39 words
The method for sealing the wall of a blood vessel having a puncture site therein according to claim 5, wherein calcium is added to one or more of the thrombin and fibrinogen solutions in concentrations of approximately 1-5 mmol/l.
Claim 8
Dependent Claim 30 words
The method for accomplishing hemostasis and sealing of a blood vessel according to claim 1, wherein Factor XIII is added to one or more of the thrombin and fibrinogen solutions.
Claim 9
Dependent Claim 36 words
The method for accomplishing hemostasis and sealing of a blood vessel according to claim 7, wherein Factor XIII is added to one or more of the thrombin and fibrinogen solutions in concentrations of approximately 20-50 μg/ml.
Claim 10
Dependent Claim 45 words
The method for sealing the wall of a blood vessel having a puncture site therein according to claim 1, wherein one or more of the following compounds is added to one or more of the thrombin and fibrinogen solutions: epsilon aminocaproic acid, aminohexanoic acid, aprotinin.
Claim 11
Dependent Claim 30 words
The method for sealing the wall of a blood vessel having a puncture site therein according to claim 9, wherein said epsilon aminocaproic acid is in concentrations of approximately 0.1-0.001M.
Claim 12
Dependent Claim 29 words
The method for sealing the wall of a blood vessel having a puncture site therein according to claim 9, wherein said aminohexanic acid is in concentrations of approximately 0.1-0.001M.
Claim 13
Dependent Claim 30 words
The method for sealing the wall of a blood vessel having a puncture site therein according to claim 9, wherein said aprotinin is in concentrations of approximately 10,000-40,000 International Units.
Claim 14
Dependent Claim 82 words
The method for sealing the wall of a blood vessel having a puncture site therein according to claim 1, further including the step of monitoring the pressure within said delivery device wherein an increase in pressure serves as an indication that said solutions transition from a liquid to a gel and further to insure that said pressure attributable to said syringe apparatus does not exceed the pressure within the vessel being sealed thereby preventing penetration of said gel into said vessel interior.
Claim 15
Dependent Claim 35 words
The method for sealing the wall of a blood vessel having a puncture site therein according to claim 1, wherein a vascular constrictor is added to one or more of the thrombin and fibrinogen solutions.
Claim 16
Dependent Claim 45 words
The method for sealing the wall of a blood vessel having a puncture site therein according to claim 14, wherein said vascular constrictor comprises epinephrine which temporarily causes the vessel at the puncture site to constrict thereby serving to facilitate sealing of the puncture site.
Claim 17
Independent Claim 191 words
A method for sealing a puncture site in the wall of a blood vessel, the puncture site having been created accidentally, or intentially during an endovascular or surgical procedure, wherein a substantially tubular percutaneous delivery device is positioned adjacent and external to a blood vessel puncture site, the method comprising the steps of: mixing a first solution containing fibrinogen with a second solution containing thrombin; allowing said mixture to interact forming a gel; applying occlusive compression to the blood vessel at a position upstream of the puncture site; releasing the occlusive compression for a brief period of time to enable the puncture site to release an amount of blood into the tissue surrounding the puncture site, sufficient to surround the immediate vicinity of the puncture site, and thereafter reapplying the occlusive compression to stop release of blood from the puncture site; delivering said gel mixture of fibrinogen and thrombin to the tissue of the patient adjacent to the puncture site but not into the blood vessel, so as to enable the gel mixture to thereafter substantially solidify around the puncture site and seal the puncture site against further release of blood.
Claim 18
Independent Claim 191 words
A method for sealing a puncture site in the wall of a blood vessel, the puncture site having been created accidentally, or intentially during an endovascular or surgical procedure, wherein a substantially tubular percutaneous delivery device is positioned adjacent and external to a blood vessel puncture site, the method comprising the steps of: mixing a first solution containing fibrinogen with a second solution containing thrombin; allowing said mixture to interact forming a gel; applying occlusive compression to the blood vessel at a position upstream of the puncture site; releasing the occlusive compression for a brief period of time to enable the puncture site to release an amount of blood into the tissue surrounding the puncture site, sufficient to surround the immediate vicinity of the puncture site, and thereafter reapplying the occlusive compression to stop release of blood from the puncture site; delivering said gel mixture of fibrinogen and thrombin to the tissue of the patient adjacent to the puncture site but not into the blood vessel, so as to enable the gel mixture to thereafter substantially solidify around the puncture site and seal the puncture site against further release of blood.
Claim 19
Independent Claim 217 words
A method for sealing a puncture site in the wall of a blood vessel, the puncture site having been created accidentally, or intentionally during an endovascular or surgical procedure, wherein a substantially tubular percutaneous delivery device is positioned adjacent a blood vessel puncture site without penetrating the vessel, the method comprising the steps of: preparing a supply of a first solution containing fibrinogen; placing said fibrinogen-containing solution in a first syringe apparatus; preparing a supply of a second solution containing thrombin; placing said thrombin-containing solution in a second syringe apparatus; applying occlusive compression to the blood vessel at a position upstream of the puncture site; connecting the first and second syringe apparatus in simultaneous fluid communication with a mixing region and thereafter the delivery device so as to enable mixing of the fibrinogen and thrombin solutions prior to delivery to the puncture site; actuating the first and second syringe apparatus so as to substantially simultaneously introduce the fibrinogen- and thrombin-containing solutions into the mixing region to form a gel and thereafter into the delivery device, and into the tissue of the patient adjacent to the puncture site but not into the blood vessel, so as to enable the gel to thereafter substantially solidify around the puncture site and seal the puncture site against further release of blood.
Claim 20
Independent Claim 217 words
A method for sealing a puncture site in the wall of a blood vessel, the puncture site having been created accidentally, or intentionally during an endovascular or surgical procedure, wherein a substantially tubular percutaneous delivery device is positioned adjacent a blood vessel puncture site without penetrating the vessel, the method comprising the steps of: preparing a supply of a first solution containing fibrinogen; placing said fibrinogen-containing solution in a first syringe apparatus; preparing a supply of a second solution containing thrombin; placing said thrombin-containing solution in a second syringe apparatus; applying occlusive compression to the blood vessel at a position upstream of the puncture site; connecting the first and second syringe apparatus in simultaneous fluid communication with a mixing region and thereafter the delivery device so as to enable mixing of the fibrinogen and thrombin solutions prior to delivery to the puncture site; actuating the first and second syringe apparatus so as to substantially simultaneously introduce the fibrinogen- and thrombin-containing solutions into the mixing region to form a gel and thereafter into the delivery device, and into the tissue of the patient adjacent to the puncture site but not into the blood vessel, so as to enable the gel to thereafter substantially solidify around the puncture site and seal the puncture site against further release of blood.

References Cited (Backward Citations)

US4367749A Cited
US4427651A Cited
US4714460A Cited
US5282827A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1998-07-31 1999-01-30 1999-08-01 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2002-07-31 2003-01-30 2003-08-01 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2006-07-31 2007-01-30 2007-08-01 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag